NHRA Pharmacist Exam cheat sheet

Bioavailability depends on aqueous solubility and membrane permeability; the Biopharmaceutics Classification System ranks drugs into four classes by these two properties.

Lipinski's rule of five flags poor oral absorption when molecular weight exceeds 500 Da, logP exceeds 5, hydrogen-bond donors exceed 5, or hydrogen-bond acceptors exceed 10.

A chiral drug's enantiomers can differ in potency, metabolism, and toxicity; thalidomide and warfarin are classic examples of stereoselective effects.

Prodrugs are inactive derivatives converted in vivo to the active agent; ester prodrugs (for example, enalapril to enalaprilat) improve absorption or prolong action.

pKa governs ionization: a weak acid is mostly ionized when pH exceeds its pKa, and a weak base is mostly ionized when pH is below its pKa.

The Henderson-Hasselbalch equation, pH = pKa + log([base]/[acid]), predicts the ionized fraction and therefore absorption across membranes.

Phase I reactions (oxidation, reduction, hydrolysis) usually introduce or expose polar groups; phase II reactions (glucuronidation, sulfation, acetylation) conjugate them for excretion.

First-pass hepatic metabolism reduces systemic availability of orally administered drugs; routes bypassing the portal circulation (sublingual, rectal, parenteral) avoid it.

First-order elimination follows the equation C = C0 × e^(−kt); half-life equals 0.693 divided by the elimination rate constant k.

Zero-order kinetics means a constant amount is eliminated per unit time, so half-life is not constant and rises as concentration falls.

Clearance equals the product of volume of distribution and elimination rate constant (Cl = Vd × k); steady state is reached after roughly four to five half-lives.

The loading dose equals (Vd × target concentration) divided by bioavailability F; the maintenance dose equals (Cl × target concentration × dosing interval) divided by F.

Sustained-release systems reduce dosing frequency by slowing dissolution or diffusion; dose dumping is a risk if the release mechanism fails.

Osmotic pump tablets release drug at a near-constant rate driven by water influx, giving true zero-order delivery.

Particle size reduction raises dissolution rate by increasing surface area, per the Noyes-Whitney relationship.

Enteric coatings resist gastric acid and dissolve above about pH 5.5, protecting acid-labile drugs or the stomach lining.

Agonists activate receptors; competitive antagonists shift the dose-response curve rightward without lowering maximal efficacy, while noncompetitive antagonists reduce maximal response.

Beta-1 receptors mediate cardiac rate and contractility; beta-2 receptors mediate bronchial and vascular smooth-muscle relaxation.

Angiotensin-converting enzyme inhibitors block conversion of angiotensin I to angiotensin II and raise bradykinin, causing cough and angioedema.

Aminoglycosides bind the bacterial 30S subunit, are bactericidal, and carry nephrotoxicity and ototoxicity risks requiring monitoring.

Warfarin inhibits vitamin K epoxide reductase, reducing synthesis of clotting factors II, VII, IX, and X; effect is monitored by INR.

Heparin acts via antithrombin III and is monitored by activated partial thromboplastin time (aPTT).

Loop diuretics inhibit the sodium-potassium-chloride cotransporter in the thick ascending limb, producing the greatest natriuresis and risk of hypokalemia.

Opioids act on mu receptors; naloxone is a competitive antagonist used for reversal of respiratory depression.

Therapeutic drug monitoring is indicated for drugs with narrow therapeutic index and good concentration-effect correlation, such as digoxin, lithium, phenytoin, and vancomycin.

Trough levels are drawn just before the next dose for most drugs; peak levels are timed according to the drug's absorption profile.

The Cockcroft-Gault equation estimates creatinine clearance from age, weight, sex, and serum creatinine to guide renal dose adjustment.

The Child-Pugh score classifies hepatic impairment and informs dose reduction for hepatically cleared drugs.

Drug interaction screening should cover CYP3A4, CYP2C9, and CYP2D6 substrates, inhibitors, and inducers before dispensing.

Antibiotic de-escalation uses culture and sensitivity results to narrow empiric therapy, reducing resistance and adverse effects.

Medication reconciliation at admission, transfer, and discharge prevents unintended discrepancies in the patient's drug list.

Therapeutic substitution requires prescriber authorization unless a formal protocol permits pharmacist-led interchange.

Prescriptions for controlled substances require prescriber registration, patient identification, drug name, strength, quantity, directions, and date.

Schedule II prescriptions generally may not be refilled; Schedule III and IV drugs permit limited refills within six months under most frameworks.

A prescription must be dispensed by or under the supervision of a registered pharmacist, and the pharmacist is accountable for its accuracy.

Pharmacists must protect patient confidentiality; disclosure requires patient consent or a legal mandate.

Pharmacists have a duty to counsel and a corresponding duty to warn of foreseeable risks, supporting negligence claims when breached.

Generic substitution is permitted when the prescriber has not prohibited it and the product is therapeutically equivalent.

Record retention rules require prescriptions and dispensing records to be kept for the period set by the national regulator.

Adverse drug reactions must be reported to the national pharmacovigilance authority, including serious and unexpected events.

Inventory turnover equals cost of goods sold divided by average inventory value; higher turnover generally indicates efficient stock control.

The economic order quantity balances ordering costs against holding costs to minimize total inventory cost.

ABC analysis classifies stock by value, with class A items (highest value) receiving the tightest control and most frequent review.

A dispensing error is a deviation from the prescriber's order; near misses should be logged and analyzed, not just actual errors.

The 'five rights' check covers right patient, right drug, right dose, right route, and right time.

Double-checking high-alert medications and separating look-alike/sound-alike products reduces selection errors.

Automated dispensing cabinets and barcode verification reduce picking errors but require periodic accuracy audits.

Staffing and workflow should separate prescribing, dispensing, and administration functions to preserve independent checks.

An adverse drug reaction is a noxious and unintended response to a drug at normal doses; causality is often graded with the Naranjo scale.

Serious adverse events include death, hospitalization, disability, congenital anomaly, or a life-threatening event, and require expedited reporting.

A type A reaction is dose-dependent and predictable from pharmacology; a type B reaction is idiosyncratic and not dose-related.

Signal detection compares observed event counts with expected rates from spontaneous reporting databases.

Medication errors are preventable events; adverse drug events may or may not be preventable.

The reporting form should capture patient details, suspect drug, dose, timing, reaction description, outcome, and concomitant drugs.

Look-alike/sound-alike name confusion and high-alert drugs (insulin, anticoagulants, opioids) are priority safety targets.

Root cause analysis of serious incidents identifies system failures rather than blaming individuals.

Percent weight-in-volume (w/v) means grams of solute per 100 mL of solution; percent weight-in-weight (w/w) means grams per 100 g of preparation.

The alligation method calculates the ratio of two strengths needed to produce an intermediate strength.

Dilution formula: C1 × V1 = C2 × V2, used for adjusting concentration of stock solutions.

Body surface area is estimated with the Mosteller formula: BSA (m²) = square root of (height in cm × weight in kg / 3600).

Pediatric doses are often scaled by body weight (mg/kg) or BSA, and the calculated dose must not exceed the adult maximum.

Isotonicity adjustment uses the sodium chloride equivalent method to add the amount of NaCl needed for 0.9% w/v.

Compounded sterile preparations require validated aseptic technique, environmental monitoring, and stability documentation.

Milliequivalent calculations convert mass to equivalents using molecular weight and valence: mEq = (mg × valence) / molecular weight.

The health belief model predicts behavior from perceived susceptibility, severity, benefits, barriers, and cues to action.

The transtheoretical model stages change as precontemplation, contemplation, preparation, action, and maintenance.

Motivational interviewing uses open questions, affirmations, reflective listening, and summarizing to build patient commitment.

Teach-back confirms understanding by asking the patient to restate instructions in their own words.

Health literacy affects adherence; plain-language labels and pictograms improve comprehension of dosing instructions.

Vaccination counseling should address contraindications, expected side effects, and the schedule appropriate to age and risk.

Screening programs follow criteria such as a common condition, reliable test, acceptable treatment, and demonstrated benefit.

Adherence interventions that combine simplification of regimen, reminders, and education outperform single-component approaches.

Enzyme kinetics: Michaelis-Menten saturation means elimination shifts from first-order at low concentration to zero-order at high concentration (phenytoin, ethanol).

Protein binding limits the free fraction; only unbound drug distributes and exerts effect, so displacement can raise free concentration transiently.

Ion trapping occurs when a weak base accumulates in acidic compartments such as lysosomes or breast milk.

Structural alerts for toxicity include nitroaromatic groups, aromatic amines, and Michael acceptors that react with nucleophiles.

Salt formation alters solubility and dissolution rate without changing the active moiety's intrinsic pharmacology.

The partition coefficient (logP) predicts lipophilicity and CNS penetration; a value near 2 often favors oral absorption.

CYP450 inhibition raises substrate concentrations and toxicity risk; induction lowers them and can cause treatment failure.

Bioequivalence is demonstrated when the 90% confidence interval of the ratio of AUC and Cmax for test versus reference falls within 80% to 125%.

The area under the curve (AUC) reflects total systemic exposure and is calculated by the trapezoidal rule from concentration-time data.

Transdermal delivery avoids first-pass metabolism but is limited to potent, low-molecular-weight, lipophilic drugs.

Suppositories may act locally or systemically; the rectal route partially avoids first-pass hepatic metabolism.

Suspensions require thixotropic behavior and appropriate suspending agents to prevent caking and ensure dose uniformity.

Sterile products for injection must be pyrogen-free and, for intravenous use, free of particulate matter.

Lyophilization improves stability of labile biologics by removing water under low temperature and pressure.

Nanoparticle carriers can improve solubility and target delivery but introduce clearance and immunogenicity considerations.

Insulin lowers blood glucose by promoting cellular uptake; hypoglycemia is its most common serious adverse effect.

Metformin reduces hepatic gluconeogenesis and improves insulin sensitivity; lactic acidosis is a rare but serious risk in renal impairment.

Beta-blockers reduce heart rate and myocardial oxygen demand; nonselective agents can cause bronchospasm in asthma.

Statins inhibit HMG-CoA reductase; myopathy and elevated transaminases require monitoring, especially with CYP3A4 inhibitors.

Corticosteroids suppress inflammation via glucocorticoid receptors; long-term use risks osteoporosis, hyperglycemia, and adrenal suppression.

NSAIDs inhibit cyclooxygenase, reducing prostaglandins; gastrointestinal ulceration and renal impairment are key risks.

Selective serotonin reuptake inhibitors carry serotonin syndrome risk when combined with other serotonergic agents.

Anticholinergic burden in older adults causes confusion, constipation, and urinary retention and should be minimized.

The SOAP note structure documents subjective findings, objective data, assessment, and plan for each patient encounter.

Vancomycin dosing targets an AUC-to-MIC ratio of 400 to 600 for serious infections, with trough monitoring as an alternative.

The CHA2DS2-VASc score estimates stroke risk in atrial fibrillation and guides anticoagulation decisions.

The Wells score estimates pretest probability of deep vein thrombosis or pulmonary embolism.

Anticoagulation reversal: vitamin K and prothrombin complex concentrate for warfarin, protamine for heparin.

Pharmacists adjust doses for renal function using measured or estimated creatinine clearance and drug-specific thresholds.

Adherence assessment should distinguish intentional nonadherence (beliefs, cost) from unintentional (forgetfulness, complexity).

Patient counseling on inhalers must include technique demonstration and rinsing after corticosteroid use to prevent oral candidiasis.

Informed consent requires disclosure of risks, benefits, and alternatives, plus patient competence and voluntariness.

Pharmacists must report suspected falsified or substandard medicines to the regulator and quarantine the product.

Good pharmacy practice requires suitable premises, temperature-controlled storage, and separation of expired stock.

Marketing authorization requires evidence of quality, safety, and efficacy before a medicine may be sold.

Ethical principles in pharmacy include beneficence, nonmaleficence, autonomy, and justice.

A conflict of interest exists when financial or personal interests could improperly influence professional judgment and must be disclosed.

Pharmacists may refuse to dispense only within legal limits and must ensure continuity of care, including referral.

Controlled substance storage requires secure, locked, access-limited areas with auditable records of receipt and dispensing.

A formulary is a continually reviewed list of approved medicines that guides prescribing and purchasing decisions.

Cost-effectiveness analysis compares cost per health outcome; cost-benefit analysis expresses outcomes in monetary terms.

Break-even point equals fixed costs divided by the contribution margin per unit.

Expired and recalled stock must be segregated, documented, and disposed of per regulatory requirements.

Refrigerated storage is typically 2 to 8 degrees Celsius; a validated temperature log detects excursions.

Patient wait time and dispensing accuracy are key operational quality indicators.

Prescription verification includes checking dose, frequency, duration, interactions, allergies, and legality.

Inventory reorder points are set from average daily usage multiplied by lead time plus a safety stock buffer.

The Naranjo algorithm scores causality from 1 to 13; scores of 9 or more indicate a definite reaction.

Spontaneous reporting suffers from underreporting and cannot establish incidence because denominators are unknown.

The Yellow Card scheme is a spontaneous reporting system for suspected adverse drug reactions.

A black triangle or equivalent symbol indicates a medicine under intensified monitoring after authorization.

Pharmacovigilance also covers medication errors, lack of efficacy, misuse, and abuse, not only adverse reactions.

Signal assessment weighs temporality, biological plausibility, dose-response, and consistency across reports.

Risk minimization measures include educational materials, restricted prescribing, and pregnancy prevention programs.

Periodic safety update reports summarize cumulative safety data at defined intervals after authorization.

Dose by weight: dose = (ordered dose per kg) × body weight, then compare against the maximum recommended dose.

Ratio strength to percent: 1:1000 converts to 0.1% w/v because 1 g in 1000 mL equals 1 g in 1000 mL.

Infusion rate in mL/h equals (dose in mcg/kg/min × weight in kg × 60) divided by concentration in mcg/mL.

Drop rate equals (volume in mL × drop factor in drops/mL) divided by time in minutes.

Creams are oil-in-water or water-in-oil emulsions; ointments are semisolid hydrocarbon bases that are more occlusive.

Compounding records must document ingredients, quantities, lot numbers, beyond-use date, and the compounder.

The displacement value of a drug is the amount of base displaced per unit mass of drug in suppository preparation.

Specific gravity converts between weight and volume: weight = volume × specific gravity for the same units.

Antimicrobial stewardship promotes appropriate selection, dose, and duration to limit resistance emergence.

Herd immunity thresholds depend on the basic reproduction number: the required immune fraction is 1 − 1/R0.

Screening test performance is described by sensitivity (true positives detected) and specificity (true negatives excluded).

Positive predictive value depends on disease prevalence and falls as prevalence decreases.

Counseling on warfarin should cover bleeding signs, dietary vitamin K consistency, and interaction avoidance.

Counseling on metered-dose inhalers includes shaking, exhaling, coordinating actuation with inhalation, and spacing doses.

Smoking cessation support combines behavioral counseling with pharmacotherapy such as nicotine replacement or varenicline.

Health promotion programs should be tailored to culture, language, and literacy level to be effective.

AUC is proportional to the administered dose divided by clearance, so changes in clearance alter exposure independent of dose.

The volume of distribution is high for lipophilic drugs that accumulate in tissue and low for highly protein-bound plasma-restricted drugs.

Metabolic drug interactions at CYP2C9 affect warfarin and phenytoin; CYP2D6 affects codeine activation and many antidepressants.

Therapeutic index equals the toxic dose divided by the effective dose; a narrow index mandates monitoring.

Eutectic mixtures of two solids can lower melting point and improve drug release or compressibility.

Polymorphism yields different crystal forms with different solubility and dissolution rates, affecting bioavailability.

Chelation with divalent cations reduces absorption of tetracyclines and fluoroquinolones.

Immediate-release tablets disintegrate and dissolve rapidly; modified-release forms alter rate, site, or timing of release.

The dissolution test is a quality control tool; the similarity factor f2 compares dissolution profiles, with values of 50 or more indicating similarity.

Ophthalmic solutions should be isotonic and buffered; suspension forms prolong corneal contact time.

Aerosol deposition in the lung depends on particle size, with roughly 1 to 5 micrometers optimal for alveolar delivery.

Preservatives in multidose containers must be compatible with the active ingredient and effective at the labeled pH.

Hydrogels and liposomes are controlled-release carriers that can reduce dosing frequency and systemic toxicity.

Container closure integrity protects sterile products from microbial ingress and must be validated.

Acetaminophen overdose depletes glutathione; N-acetylcysteine replenishes it and is most effective when given early.

Digoxin inhibits the sodium-potassium ATPase and increases vagal tone; toxicity signs include nausea, visual changes, and arrhythmia.

Levothyroxine is dosed on an empty stomach and monitored by thyroid-stimulating hormone levels.

Proton pump inhibitors irreversibly inhibit the gastric hydrogen-potassium ATPase, producing prolonged acid suppression.

Antihistamines block H1 receptors; first-generation agents cause sedation through central H1 blockade.

Methotrexate at low doses for inflammatory disease is taken weekly, and daily dosing errors can be fatal.

Antiepileptic drugs such as phenytoin show saturable metabolism, so small dose increases can cause toxicity.

Bronchodilators include beta-2 agonists for rapid relief and antimuscarinics for sustained bronchodilation.

The medication appropriateness index evaluates indication, effectiveness, dose, interactions, duplication, and duration.

Beers criteria list potentially inappropriate medications for older adults, such as long-acting benzodiazepines.

Drug-induced liver injury should be suspected when transaminases rise after starting a new medication.

Serotonin syndrome presents with agitation, hyperthermia, clonus, and tremor after serotonergic combination therapy.

Neuroleptic malignant syndrome presents with rigidity, fever, autonomic instability, and elevated creatine kinase.

Therapeutic failure may reflect nonadherence, inadequate dose, poor absorption, or drug interaction; each should be assessed.

Counseling on anticoagulants includes recognizing bleeding, avoiding NSAIDs, and informing providers before procedures.

Transition-of-care counseling should confirm the patient knows which medicines were stopped, started, or changed.

Pharmacovigilance obligations continue after marketing and include periodic safety reporting and risk management plans.

Labeling must include approved indications, dosing, contraindications, warnings, and storage conditions.

Advertising of prescription medicines to the public is restricted or prohibited in many jurisdictions.

Pharmacists must keep professional competence current through continuing education required for licensure.

Dispensing errors must be disclosed to the patient and prescriber when harm is possible, per ethical duty of candor.

Patient records must be accurate, contemporaneous, and retained for the legally defined period.

Special controls apply to narcotics and psychotropics, including physical security and transaction reporting.

Research involving human subjects requires ethics committee approval and informed consent before enrollment.

Standard operating procedures standardize repetitive tasks and support consistency during staff turnover.

A just culture distinguishes human error from at-risk and reckless behavior when responding to incidents.

Key performance indicators for dispensing include error rate, turnaround time, and stockout frequency.

Queue management and triage of prescriptions by urgency reduce patient waiting and prioritize acute needs.

Staff competency assessment should be documented for aseptic technique and high-risk dispensing tasks.

Insurance and reimbursement processes require verification of eligibility, coding accuracy, and timely claim submission.

Controlled drug registers must record receipts, issues, and balances and be reconciled regularly.

Workplace safety includes handling hazardous drugs with appropriate personal protective equipment and containment.

The Uppsala Monitoring Centre maintains the global individual case safety report database for signal detection.

Causality categories include certain, probable, possible, unlikely, and unassessable, based on temporal and biological criteria.

Dechallenge and rechallenge observations strengthen causality assessment when ethically acceptable.

A cluster of similar reports within a short period warrants prompt review even before formal confirmation.

High-alert medications require independent double checks, standardized concentrations, and clear labeling.

Tall-man lettering reduces confusion between look-alike drug names such as DOBUTamine and DOPamine.

Failure mode and effects analysis proactively identifies where a process could fail and its severity.

Medication error reporting should be nonpunitive to encourage disclosure and learning.

Dilution of alcohol: use the alligation or the C1V1 = C2V2 relationship to reach a target proof strength.

Capsule filling: total powder mass equals the sum of active ingredient and diluent needed for the prescribed number of capsules.

Cream and ointment calculations often require converting percent w/w to grams of drug per total batch mass.

Sodium chloride equivalent: grams of NaCl equivalent = weight of drug × E value; subtract from 0.9% total to find added NaCl.

Half-life calculation: number of half-lives = elapsed time divided by half-life; remaining fraction = (1/2)^n.

IV flow rate in drops per minute equals (volume × drop factor) divided by time in minutes.

Beyond-use dates for nonsterile compounded preparations depend on the dosage form and water content.

Weighing accuracy requires that the smallest quantity weighed be no less than the balance's minimum weighable amount.

Epidemiological measures include incidence (new cases) and prevalence (all existing cases at a time).

Relative risk compares incidence in exposed versus unexposed groups; odds ratio approximates it in case-control studies.

Attributable risk estimates the excess disease burden linked to an exposure in the population.

Primary prevention reduces exposure before disease; secondary prevention detects disease early; tertiary prevention limits disability.

Counseling should be documented, including topics covered and the patient's demonstrated understanding.

Written materials should be at roughly a sixth-grade reading level and supplemented with verbal explanation.

Barriers to adherence include cost, side effects, complex regimens, and health beliefs; each should be explored.

Antibiotic counseling should stress completing the prescribed course and avoiding sharing leftover medicines.

The Nernst equation relates membrane potential to ion concentration gradients and underlies drug effects on excitable tissue.

Stereochemistry affects receptor fit: (S)-warfarin is more potent as a vitamin K antagonist than (R)-warfarin.

Ester and amide hydrolysis differ in rate; amides are more stable and require hepatic amidases.

Therapeutic peptides and proteins are degraded by gastric enzymes, so they usually require parenteral administration.

Enterohepatic recirculation prolongs drug effect when conjugates are hydrolyzed by gut flora and reabsorbed.

The apparent volume of distribution is calculated as dose divided by plasma concentration after distribution.

Structure-activity relationship studies modify functional groups to optimize potency while limiting toxicity.

Excipients serve as diluents, binders, disintegrants, lubricants, and glidants; magnesium stearate is a common lubricant.

Tablet hardness and friability tests assess mechanical strength and resistance to abrasion during handling.

Film coating masks taste and improves swallowability, while sugar coating is thicker and more time-consuming.

Emulsion stability requires an appropriate emulsifier and prevention of coalescence and phase separation.

Gels are semisolid systems with a three-dimensional network that immobilizes the liquid phase.

Osmotic and matrix systems are common oral extended-release designs; matrix release often follows Higuchi kinetics.

Sterilization methods include moist heat, dry heat, filtration, and radiation, chosen by product stability.

Angiotensin receptor blockers block the AT1 receptor and avoid bradykinin-mediated cough seen with ACE inhibitors.

Calcium channel blockers reduce calcium influx; dihydropyridines act mainly on vasculature, non-dihydropyridines on the heart.

Loop and thiazide diuretics lower potassium, while potassium-sparing diuretics can cause hyperkalemia.

Benzodiazepines enhance GABA-A chloride currents; flumazenil is an antagonist for overdose.

Antipsychotics block dopamine D2 receptors; extrapyramidal symptoms are more common with typical agents.

Levothyroxine and warfarin interactions require monitoring because thyroid status alters clotting factor catabolism.

Antitubercular therapy with rifampin induces CYP enzymes, reducing concentrations of many co-administered drugs.

Allopurinol inhibits xanthine oxidase and lowers uric acid, but can precipitate a flare if started during an acute attack.

Renal dose adjustment uses creatinine clearance bands; many drugs require reduced dose or extended interval below 30 mL/min.

Potassium monitoring is required with ACE inhibitors, potassium-sparing diuretics, and trimethoprim.

Blood glucose monitoring frequency depends on insulin regimen, hypoglycemia risk, and patient capability.

Asthma control is assessed by daytime symptoms, night waking, reliever use, and activity limitation.

Heart failure therapy includes ACE inhibitors or ARBs, beta-blockers, and mineralocorticoid receptor antagonists.

Antibiotic duration should follow evidence-based guidelines; prolonged courses increase resistance and adverse effects.

Patient counseling for new prescriptions covers purpose, dose, timing, duration, side effects, and storage.

Clinical documentation should record the recommendation, the prescriber's response, and the follow-up plan.

A prescription is valid only when issued by a legally authorized prescriber within their scope of practice.

Pharmacists must verify prescription authenticity and may decline to dispense when forgery is suspected.

Substitution laws vary; when substitution is allowed, the patient must be informed and records must note the product dispensed.

Pharmacists have a duty to report adverse events and suspected product quality defects to the regulator.

Professional indemnity insurance and adherence to standards of practice support risk management.

Privacy laws limit use and disclosure of health information to the minimum necessary for care.

Emergency contraception and other time-sensitive medicines require prompt dispensing and counseling.

Pharmacists must avoid discriminatory practice and ensure equitable access to medicines and advice.

Prescription screening includes allergy check, dose range check, therapeutic duplication, and interaction review before dispensing.

Labeling must include patient name, drug name and strength, directions, quantity, date, and storage instructions.

Dispensing workflow separates data entry, filling, and verification to create independent checks.

Stock rotation follows first-expiry-first-out principles to reduce waste.

Refrigerator and room temperature logs should be reviewed regularly and excursions investigated.

Patient identification should be confirmed using at least two identifiers before handing over medicines.

Pharmacy layout should separate clean compounding areas from dispensing and storage to reduce contamination.

Staff training on look-alike products and high-alert medicines should be documented and refreshed.

Adverse event reporting should occur even when causality is uncertain; the reporter need not prove causation.

Serious unexpected suspected adverse reactions require expedited reporting within a short regulatory timeframe.

Pregnancy exposure registries collect outcome data for medicines used during pregnancy.

Risk evaluation and mitigation strategies may require restricted distribution, patient registries, or prescriber certification.

Medication error analysis should classify errors by stage: prescribing, transcribing, dispensing, administering, monitoring.

Intercepting a near miss is a safety success and should be recorded for learning.

Anticoagulant safety programs focus on dosing, monitoring, and patient education to reduce bleeding events.

Insulin safety requires standardized concentrations, dedicated devices, and clear unit-based labeling.

Percent error in compounding equals the absolute difference between measured and desired quantity divided by desired quantity, times 100.

Dilution of a concentrated solution: volume of stock = (final concentration × final volume) divided by stock concentration.

Pediatric dose by BSA: dose = (BSA of child in m² / 1.73 m²) × adult dose.

Milligrams per milliliter to percent w/v: divide mg/mL by 10 to obtain percent.

Mixing two solutions of different strengths uses alligation medial to find the final strength and alligation alternate to find proportions.

Insulin syringe units must match the insulin concentration to avoid dosing errors.

Compounding a suspension requires a suspending agent and uniform dispersion before dispensing.

Ointment preparation by fusion requires heating bases to a uniform melt and stirring until congealed.

Vaccine cold chain integrity must be maintained from manufacture to administration, with temperature monitoring at each step.

Public health surveillance detects outbreaks early and informs rapid response measures.

Screening programs require follow-up and treatment pathways; a test alone does not improve outcomes.

Counseling on chronic disease should set specific, measurable, achievable goals negotiated with the patient.

Health education materials should be evaluated for readability and cultural appropriateness before use.

Pharmacists can support smoking cessation, diabetes education, and hypertension monitoring as public health roles.

Adverse drug event prevention at the population level includes safe prescribing education and monitoring programs.

Community engagement and accessible pharmacy hours improve equity in access to medicines and advice.

The rate of passive diffusion follows Fick's law: flux is proportional to concentration gradient and surface area, and inversely proportional to membrane thickness.

Carrier-mediated transport can be saturated, showing Michaelis-Menten kinetics, and may be competitive or noncompetitive.

P-glycoprotein efflux at the intestine and blood-brain barrier limits oral absorption and CNS entry of substrates.

Salt hydrolysis can alter solution pH and stability; buffer selection depends on the drug's degradation pH profile.

Photodegradation requires amber containers or opaque packaging for light-sensitive drugs such as nifedipine.

Oxidation of drugs with phenolic or catechol groups is slowed by antioxidants and chelating agents.

Therapeutic drug monitoring relies on the assumption that plasma concentration correlates with effect site concentration.

Bioavailability of an oral dose is reduced by incomplete absorption, first-pass metabolism, and formulation factors.

A generic product must show pharmaceutical equivalence and bioequivalence to the reference product.

Suppository bases include theobroma oil (melting at body temperature) and polyethylene glycol (dissolving in rectal fluid).

Pessaries and vaginal rings provide local or systemic delivery with prolonged residence time.

Inhaler devices include metered-dose, dry-powder, and nebulized systems, each with distinct technique requirements.

Parenteral routes include intravenous, intramuscular, and subcutaneous, differing in onset and volume limits.

Sterile filtration uses a 0.22-micrometer filter to remove bacteria from heat-labile solutions.

Antiplatelet agents include aspirin (irreversible cyclooxygenase-1 inhibition) and clopidogrel (P2Y12 receptor blockade).

Thrombolytics activate plasminogen to plasmin, dissolving clots but carrying bleeding risk.

Beta-2 agonists relieve bronchospasm; overuse signals inadequate asthma control.

Inhaled corticosteroids reduce airway inflammation and are the mainstay of persistent asthma control.

Antiemetics target different pathways: 5-HT3, dopamine D2, histamine H1, and neurokinin NK1 receptors.

Laxatives differ by mechanism: bulk-forming, osmotic, stimulant, and stool softeners.

Antihypertensive combinations should avoid duplicating mechanisms and should account for comorbidity.

Antifungal azoles inhibit ergosterol synthesis and are CYP3A4 inhibitors, raising interaction risk.

The medication history should include prescription drugs, over-the-counter products, supplements, and adherence patterns.

Allergy documentation should distinguish true allergy from intolerance and record the reaction type.

Dose adjustment in obesity may require ideal or adjusted body weight for selected drugs.

Monitoring parameters should be matched to drug toxicity: renal function for aminoglycosides, INR for warfarin, TSH for levothyroxine.

Patient education on hypoglycemia should cover symptoms, treatment, and when to seek help.

Deprescribing should be considered when harms outweigh benefits, especially in polypharmacy.

Interprofessional communication should be documented and closed-loop, with confirmation of receipt.

Follow-up intervals should match the drug's onset, risk period, and the patient's stability.

A medication recall classification indicates the health hazard level; class I recalls involve serious harm risk.

Pharmacists must verify that imported or unapproved products meet regulatory requirements before dispensing.

Prescription monitoring programs track controlled substance dispensing to detect misuse.

Pharmacists must maintain appropriate records for controlled substances and make them available for inspection.

Professional boundaries require avoiding exploitative relationships with patients.

Conflicts between patient welfare and business interests must be resolved in favor of patient welfare.

Whistleblowing may be ethically required when serious harm is not addressed internally.

Informed refusal of treatment should be documented after the patient understands the consequences.

Demand forecasting uses historical dispensing data adjusted for seasonality and prescribing trends.

Safety stock protects against variability in demand and lead time; higher variability requires larger buffers.

Inventory valuation methods include FIFO and weighted average cost, affecting reported stock value.

Automated counting devices require periodic calibration and accuracy verification.

Pharmacy information systems should have access controls and audit trails for dispensing records.

Customer service standards should include privacy during counseling and clear communication of wait times.

Waste reduction includes monitoring expiry dates and returning near-expiry stock where permitted.

Business continuity planning addresses system outages and supply disruptions.

Adverse drug reaction reports should include the outcome and any relevant laboratory data.

Duplicate reports should be consolidated to avoid inflating signal counts.

Signal evaluation considers strength of association, consistency, and biological plausibility.

Regulatory action may include label changes, restrictions, suspension, or withdrawal.

Medication safety indicators include prescribing errors, dispensing errors, and administration errors.

Patient engagement in safety includes encouraging reporting of side effects and asking questions.

Safety communication should be timely, clear, and targeted to the relevant prescriber groups.

Post-authorization studies may be required to assess long-term safety in real-world use.

Concentration conversion: percent strength to mg/mL multiplies percent by 10.

Dose calculation for a child by weight should be checked against the adult dose to detect errors.

Infusion duration equals total volume divided by flow rate.

Reconstitution calculations must account for the powder volume displaced by the diluent.

Compounding a solution requires accurate measurement of solvent volume after drug dissolution.

Ointment strength conversion from percent w/w to mg/g multiplies percent by 10.

Capsule size selection depends on the total fill mass and powder density.

Sterile compounding calculations must include overfill allowances for vial and bag preparation.

Health behavior change is more likely when the patient perceives the change as personally relevant.

Counseling should use plain language and avoid unnecessary jargon.

Screening for adherence barriers should include cost, access, and side-effect concerns.

Vaccine hesitancy should be addressed with listening, empathy, and factual information.

Community pharmacy can serve as an access point for screening and chronic disease monitoring.

Health promotion should consider social determinants such as income, housing, and education.

Patient counseling should be documented and repeated at follow-up visits.

Counseling on storage should include temperature, light, and moisture protection.

The dissociation constant pKa determines the fraction ionized at a given pH and therefore membrane permeability.

Lipid solubility and ionization together determine the rate of passive absorption.

Drug metabolism can produce active metabolites, as with codeine to morphine.

Enzyme induction increases metabolism and can reduce efficacy of co-administered drugs.

Protein binding displacement is usually transient unless elimination is also impaired.

Therapeutic drug monitoring requires steady-state sampling for drugs with long half-lives.

Chemical stability studies assess degradation under heat, light, and humidity.

Tablet compression involves granulation, blending, and compression steps that affect dissolution.

Coating defects include cracking, peeling, and bridging, often from formulation or process issues.

Suspension sedimentation rate is described by Stokes' law and reduced by smaller particles and higher viscosity.

Emulsion type can be identified by dilution and dye tests.

Suppository displacement values ensure accurate drug content per unit.

Ophthalmic ointments prolong contact time but can blur vision.

Nebulizer output depends on gas flow, fill volume, and device design.

Beta-blocker withdrawal can cause rebound tachycardia and angina.

Nitrates cause venodilation and reduce preload; tolerance develops with continuous exposure.

Diuretic resistance may require combination therapy or increased dose.

Opioid tolerance and dependence are distinct from addiction.

Anticoagulant choice depends on renal function, interactions, and monitoring feasibility.

Antibiotic spectrum should match the likely pathogen and local resistance patterns.

Drug interactions can be pharmacokinetic or pharmacodynamic.

Adverse effects often reflect the drug's primary pharmacology.

Medication review should assess indication, effectiveness, safety, and adherence.

Renal function estimation should use a validated equation appropriate to the patient.

Monitoring plans should specify parameter, frequency, and action thresholds.

Patient counseling should confirm understanding with teach-back.

Documentation should be clear enough for another clinician to follow.

Follow-up should address barriers and adverse effects.

Interprofessional collaboration improves medication safety.

Deprescribing should be considered when risks exceed benefits.

Prescription validity depends on prescriber authority and legal requirements.

Controlled substance records must be accurate and auditable.

Patient confidentiality must be protected except where law requires disclosure.

Recall handling requires quarantine and documentation.

Professional standards require competence and continuing education.

Ethical decisions should prioritize patient welfare.

Advertising restrictions apply to prescription medicines.

Research requires ethics approval and informed consent.

Dispensing accuracy depends on independent verification steps.

Inventory control balances stock availability against holding costs.

Temperature monitoring protects product quality.

Staff competency should be documented.

Workflow design should separate filling and checking.

High-alert medicines require additional safeguards.

Patient identification should use two identifiers.

Expired stock must be segregated and disposed of properly.

Adverse event reporting should be timely and complete.

Causality assessment uses temporal and biological criteria.

Signal detection compares observed and expected events.

Serious events require expedited reporting.

Near misses should be recorded and analyzed.

High-alert medicines require double checks.

Root cause analysis focuses on system failures.

Risk minimization measures should be evaluated for effectiveness.

Dose calculations should be checked against maximum limits.

Concentration conversions require consistent units.

Alligation calculates mixing ratios for target strength.

Compounding records must document ingredients and beyond-use dates.

Isotonicity calculations use sodium chloride equivalents.

Infusion rates depend on concentration and prescribed dose.

Pediatric doses are scaled by weight or BSA.

Weighing accuracy depends on balance sensitivity.

Health behavior models guide counseling strategies.

Screening programs require follow-up and treatment.

Vaccination counseling should address safety and schedule.

Plain-language materials improve comprehension.

Adherence support should address cost and complexity.

Motivational interviewing builds commitment to change.

Health promotion should consider social determinants.

Counseling should be documented and repeated.